Evidence map›Paper›PMID 39868286›Full record

ArticlebioRxiv : the preprint server for biology2025

Structural mechanism for recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F.

Peter Ngoi, Xianxi Wang, Sivasankar Putta, Ricardo F Da Luz, Vitor Hugo B Serrão, Michael J Emanuele, Seth M Rubin

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Peter NgoiDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA.
Xianxi WangDepartment of Pharmacology and Lineberger Comprehensive Cancer Center. The University of North Carolina, Chapel Hill, NC.
Sivasankar PuttaDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA.
Ricardo F Da LuzDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA.
Vitor Hugo B SerrãoDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA.ORCID 0000-0002-9398-2941
Michael J EmanueleDepartment of Pharmacology and Lineberger Comprehensive Cancer Center. The University of North Carolina, Chapel Hill, NC.ORCID 0000-0003-4104-7449
Seth M RubinDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA.ORCID 0000-0002-1670-4147

Funding

Project 3: Defining and targeting mechanisms of E2F transcription factor regulationP01CA254867 · NCI · STANFORD UNIVERSITY · PI Jan M Skotheim · 2022 to 2026
$8.9M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Molecular Mechanisms of Cell Cycle Dependent Gene ExpressionR35GM145255 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Seth Michael Rubin · 2022 to 2026
$3.0M
Proteostasis signaling in cell cycle controlR35GM153250 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael James Emanuele · 2024 to 2026
$1.9M
NCI NIH HHS P01 CA254867NIGMS NIH HHS R01 GM129325NIGMS NIH HHS R35 GM145255NIGMS NIH HHS R35 GM153250
6 · The paper itself

Abstract

Cyclin F, a non-canonical member of the cyclin protein family, plays a critical role in regulating the precise transitions of cell-cycle events. Unlike canonical cyclins, which bind and activate cyclin-dependent kinases (CDKs), Cyclin F functions as a substrate receptor protein within the Skp1-Cullin-F box (SCF) E3 ubiquitin ligase complex, enabling the ubiquitylation of target proteins. The structural features that distinguish Cyclin F as a ligase adaptor and the mechanisms underlying its selective substrate recruitment over Cyclin A, which functions in complex with CDK2 at a similar time in the cell cycle, remain largely unexplored. We utilized single-particle cryo-electron microscopy to elucidate the structure of a Cyclin F-Skp1 complex bound to an E2F1 peptide. The structure and biochemical analysis reveal important differences in the substrate-binding site of Cyclin F compared to Cyclin A. Our findings expand on the canonical cyclin-binding motif (Cy or RxL) and highlight the importance of electrostatics at the E2F1 binding interface, which varies for Cyclin F and Cyclin A. Our results advance our understanding of E2F1 regulation and may inform the development of inhibitors targeting Cyclin F.

Identifiers

PMID39868286
PMCPMC11761524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.